-
Institutional Trends and Healthcare Resource Utilization in Real-World NMIBC and MIBC Treatment in Germany
Sep 9, 2025, 16:22 PM -
External Reference Pricing (ERP) Availability vs. Reimbursement Timelines in Poland and Other European Countries: The Analysis of EURIPID Database
Sep 9, 2025, 16:22 PM -
Scaling Responsible Healthcare Data Access With AI-Driven Sensitive Patient Variable Detection
Sep 9, 2025, 16:22 PM -
Assessing Stakeholders’ Perceptions of the EU Health Technology Assessment Regulation and Access to Innovative Medicines in Europe and the Netherlands: Challenges, Opportunities, and Recommendations
Sep 9, 2025, 16:22 PM -
Multistakeholder Survey on Communication of Uncertainties in Cost-Effectiveness Analysis by the Institute of Clinical and Economic Review
Sep 9, 2025, 16:22 PM -
Comparing the Economic Burden in Patients With vs. Without Ehlers-Danlos Syndrome (EDS) Using a Large US Electronic Health Records Database
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization in Adults with Type 1 Diabetes Who Have a Prior Type 2 Diabetes Misdiagnosis and Recorded HbA1c in a US Managed Care Population
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis: A Case Study of Obesity
Sep 9, 2025, 16:22 PM -
An Analysis of Differences in Patient Access to CGRP Migraine Treatments in the Nordic Region
Sep 9, 2025, 16:22 PM -
Routing Decisions and Outcomes of NICE Technology Appraisals Underproportionate Approach to Technology Appraisals
Sep 9, 2025, 16:22 PM -
The New Discount on Combination Drug Therapies in Germany: First Numbers and Assessment From a Payor Perspective
Sep 9, 2025, 16:22 PM -
Win Ratio in the Presence of Censored Data: Can Probabilistic Variants Improve Robustness?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact Analysis of Noninvasive Prenatal Testing (NIPT) for the Identification of Fetal Chromosomal Aneuploidies in Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Expanded Access to Oncology Therapies in Mexico: The Role of Bioequivalent Abiraterone and Axitinib
Sep 9, 2025, 16:22 PM -
From Evidence to Excel: Generative AI for Automated SLR Data Extractions
Sep 9, 2025, 16:22 PM -
Primary Lateral Sclerosis (PLS): A Targeted Literature Review of Symptoms, Progression, and Outcomes to Inform Evidence Gaps for Rare Neurological Disorders
Sep 9, 2025, 16:22 PM -
Rare Disease Awareness Among Physicians in Five European Countries: Results of a Cross-Sectional Survey
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on the Resource Impact of Subcutaneous vs. Intravenous Atezolizumab in an NHS Cancer Center
Sep 9, 2025, 16:22 PM -
Evaluating EU-HTA PICO Exercise Outcomes: Duration of Response and Time to Response in Hepatocellular Carcinoma Using Randomization-Preserving Methods with IMbrave150 Data
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness and Budget Impact of Increasing Peritoneal Dialysis Utilization Among End-Stage Kidney Disease Patients in South Korea
Sep 9, 2025, 16:22 PM
